A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Fixed Dose Combination of Biktarvy versus Tivicay and Descovy in Treatment Naive, HIV-1 and Hepatits B CoInfected Adults

By |2019-04-23T19:32:02+00:00April 23rd, 2019|